Details:

Alternative Title:
Cancer Epidemiol
Publisher's site:
http://dx.doi.org/10.1016/j.canep.2016.11.001
Personal Author:
Clarke, Christina A.; Glaser, Sally L.; Leung, Rita; Davidson-Allen, Kathleen; Gomez, Scarlett L.; ... More +
Clarke, Christina A.; Glaser, Sally L.; Leung, Rita; Davidson-Allen, Kathleen; Gomez, Scarlett L.; Keegan, Theresa H.M.; Less -
Description:
Introduction Patients may receive cancer care from multiple institutions. However, at the population level, such patterns of cancer care are poorly described, complicating clinical research. To determine the population-based prevalence and characteristics of patients seen by multiple institutions, we used operations data from a state-mandated cancer registry. Methods and materials 59,672 invasive cancers diagnosed in 1/1/2010-12/31/2011 in the Greater Bay Area of northern California were categorized as having been reported to the cancer registry within 365 days of diagnosis by: 1) ≥1 institution within an integrated health system (IHS); 2) IHS institution(s) and ≥1 non-IHS institution (e.g., private hospital); 3) 1 non-IHS institution; or 4) ≥2 non-IHS institutions. Multivariable logistic regression was used to characterize patients reported by multiple vs. single institutions. Results Overall in this region, 17% of cancers were reported by multiple institutions. Of the 33% reported by an IHS, 8% were also reported by a non-IHS. Of non-IHS patients, 21% were reported by multiple institutions, with 28% for breast and 27% for pancreatic cancer, but 19%% for lung and 18% for prostate cancer. Generally, patients more likely to be seen by multiple institutions were younger or had more severe disease at diagnosis. Conclusions Population-based data show that one in six newly diagnosed cancer patients received care from multiple institutions, and differed from patients seen only at a single institution. Cancer care data from single institutions may be incomplete and possibly biased.
Subject:
[+]
Adult
Aged
Article
Female
Humans
Male
Middle Aged
Neoplasms
Prevalence

Source:
Cancer Epidemiol. 46:27-33.;
Pubmed ID:
27918907
Pubmed Central ID:
PMC5759969
Document Type:
Journal Article;
Funding:
U58 DP003862/DP/NCCDPHP CDC HHS/United States; HHSN261201000140C/CA/NCI NIH HHS/United States; HHSN261201000035C/CA/NCI NIH HHS/United States; P30 CA124435/CA/NCI NIH HHS/United States; HHSN261201000034C/CA/NCI NIH HHS/United States; ... More +
U58 DP003862/DP/NCCDPHP CDC HHS/United States; HHSN261201000140C/CA/NCI NIH HHS/United States; HHSN261201000035C/CA/NCI NIH HHS/United States; P30 CA124435/CA/NCI NIH HHS/United States; HHSN261201000034C/CA/NCI NIH HHS/United States; N01 PC035137/PC/NCI NIH HHS/United States; Less -
Collection(s):
CDC Public Access
Main Document Checksum:
[+]
urn:sha256:9bdd3a74adcb7851913afcaca9d6059836c0d71dc0feab48c541c1fbf3a85134
File Type:

Supporting Files

• nihms928971.nxml

  xml

More +